Elsener M, Ferrafiat M, de Bruyn M, Jouhet P, Robert Y, Rouge P E
Clinique Mutualiste des Eaux Claires de Grenoble.
Rev Fr Gynecol Obstet. 1988 Nov;83(11):697-701.
Starting from the structural analogy between bromo-ergocryptine (Parlodel) and dihydroergocryptine caffeine (Vasobral), as well as with dihydroergotoxine (Hydergine), the authors decided to test the efficacy of the last two products in inhibiting post-partum physiological milk secretion. Twelve patients will be treated with either one of the two products, with a clinical and biological efficacy (serum prolactin level assay) which is comparable to that found in the literature regarding Parlodel. This study confirm the results obtained in a study of the inhibition of hyper-prolactinemia of other origin, by the same authors.
基于溴麦角环肽( Parlodel)与二氢麦角隐亭咖啡因(Vasobral)以及二氢麦角毒碱(海得琴)之间的结构相似性,作者决定测试后两种产品抑制产后生理性乳汁分泌的效果。12名患者将接受这两种产品中的一种治疗,其临床和生物学疗效(血清催乳素水平检测)与文献中关于Parlodel的疗效相当。这项研究证实了同一作者在另一项关于抑制其他原因引起的高催乳素血症的研究中所获得的结果。